NDC product
ANTI-DIARRHEAL
NDC 80136-851 · Northeast Pharma
Key facts
| Product NDC | 80136-851 |
|---|---|
| Proprietary name | ANTI-DIARRHEAL |
| Nonproprietary name | LOPERAMIDE HYDROCHLORIDE |
| Substances | LOPERAMIDE HYDROCHLORIDE |
| Dosage form | CAPSULE, LIQUID FILLED |
| Route | ORAL |
| Labeler | Northeast Pharma |
| Product type | HUMAN OTC DRUG |
| Marketing category | NDA |
| Application number | NDA021855 |
| Pharmacologic classes | Opioid Agonist [EPC], Opioid Agonists [MoA] |
| Marketing start | May 21, 2021 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: